(Total Views: 94)
Posted On: 09/22/2022 9:55:49 AM
Post# of 104413
$SPRO News Article - GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr https://marketwirenews.com/news-releases/gsk-...08051.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
